RxDoctor Payments Data

Ian Russinoff, MD

Emergency Medicine · West Palm Beach, FLNPI 1477548295

Payments from drug & device makers

$1,639in general payments, 2019–2025

Across 52 payments — averaging $31.51 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Inari Medical, Inc.$187
  • Lilly USA, LLC$177
  • Johnson & Johnson$168
  • GSK$166
  • Amgen$155
  • Abiomed$146
  • plus $640 from 13 others

What the payments were for

  • Food & beverage$1,639100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,639 in reported general payments places this provider in the 95th percentile of 3,289 emergency medicine providers in Florida.

See all emergency medicine providers in Florida

Medicare billing

Part B allowed, 2024
$52,849
Medicare patients
143
Services billed
843

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide24$26,816
MounjaroTirzepatide23$22,605
Effexor XrVenlafaxine Hcl13$13,299
Ezetimibe19$481
Pantoprazole Sodium37$464
Zolpidem Tartrate53$413
Atorvastatin Calcium28$329
Rosuvastatin Calcium14$311
Albuterol Sulfate HfaAlbuterol Sulfate17$310
Amlodipine Besylate34$289
Levothyroxine Sodium21$287
Doxycycline Hyclate21$234
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav26$217
Escitalopram Oxalate13$202
Losartan Potassium17$164

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$19$26,81624 claims
Lilly USA, LLCMounjaro$177$22,60523 claims
PfizerEffexor Xr$102$13,29913 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 3,289 emergency medicine providers in Florida.

Other emergency medicine in West Palm Beach

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →